Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Check-Cap Ltd.

COMPANY HAS SUSPENDED CALLS SINCE THE SECOND QUARTER OF 2024 TO AVOID FACING THE MUSIC FOR BOARD'SAND MANAGEMENT TEAM'S DESTRUCTION OF 99% OF STOCK'S VALUE, COSTING SHAREHOLDERS $1 BILLION CONFERENCE CALL IS A BLATANT, SELF-SERVING REACTION BY A MANAGEMENT TEAM RUNNING SCARED FOLLOWINGAPOLLO CAPITAL'S INTENTION TO NOMINATE SIX HIGHLY QUALIFIED DIRECTORS TO MEDIPHARM'SBOARD SHAREHOLDERS DESERVE ANSWERS FROM MANAGEMENT ABOUT MASSIVEUNDERPERFORMANCE, FAILED OPERATIONAL STRATEGIES, POOR CAPITAL ALLOCATION, OUTRAGEOUS COMPENSATION, AND LACK OF TRANSPARENCY APOLLO CAPITAL'S NOMINEES BRING SIGNIFICANT TURNAROUND, M&A, AND OPERATIONAL EXPERIENCE IN CANNABISAND ADJACENT INDUSTRIES, AND WILL EXECUTE PLAN TO RESTORE VALUE FOR ALL MEDIPHARM SHAREHOLDERS URGES MEDIPHARM SHAREHOLDERS TO VOTE FOR WHOLESALE CHANGE AT ANNUAL MEETING TORONTO , MAY 14, 2025 /PRNEWSWIRE/ --APOLLO TECHNOLOGY CAPITAL CORPORATION ("APOLLO CAPITAL"), WHICH TOGETHER WITH ITS AFFILIATES AND ASSOCIATES COLLECTIVELY IS ONE OF THE LARGEST SHAREHOLDERS OF MEDIPHARM LABS CORP. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MEDIPHARM", "MEDIPHARM LABS", OR THE "COMPANY"), OWNING APPROXIMATELY 3.0% OF THE COMPANY'S COMMON STOCK, TODAY POSED SEVERAL CRITICAL QUESTIONS THAT SHAREHOLDERS SHOULD ASK MEDIPHARM MANAGEMENT ON THIS MORNING'S CONFERENCE CALL FOLLOWING ITS FIRST QUARTER 2025 EARNINGS REPORT. CEO DAVID PIDDUCK AND HIS MANAGEMENT TEAM HAVE NOT HELD A CALL WITH SHAREHOLDERS SINCE THE SECOND QUARTER OF 2024 TO AVOID HAVING TO DEFEND THEMSELVES AFTER DESTROYING 99% OF THE VALUE OF THE COMPANY'S STOCK, OR NEARLY $1 BILLION.

APOLLO TECHNOLOGY CAPITAL CORPORATION POSES QUESTIONS THAT MEDIPHARM SHAREHOLDERS SHOULD ASK ON MANAGEMENT'S CONFERENCE CALL WITH SHAREHOLDERS

TORONTO , MAY 13, 2025 /PRNEWSWIRE/ -MEDIPHARM LABS CORP. (TSX: LABS) ("MEDIPHARM" OR THE "COMPANY"), A PHARMACEUTICAL COMPANY SPECIALIZED IN PRECISION-BASED CANNABINOIDS, HAS FILED ITS MANAGEMENT INFORMATION CIRCULAR ("MIC" OR THE "CIRCULAR") AND PROXY MATERIALS (THE "MEETING MATERIALS") FOR ITS UPCOMING ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS, SCHEDULED FOR JUNE 16, 2025. THE MEETING MATERIALS WILL BE SENT TO SHAREHOLDERS IN THE COMING DAYS, AND ARE AVAILABLE ON THE SEDAR+ WEBSITE AT WWW.SEDARPLUS.CA.

MEDIPHARM LABS FILES PROXY MATERIALS, ISSUES CHAIR'S LETTER TO SHAREHOLDERS

BELIEVES BOARD CHANGE IS URGENTLY NEEDED: UNDER THE CURRENT BOARD AND MANAGEMENT, MEDIPHARM STOCK PRICE IS DOWN MORE THAN 99%, COSTING SHAREHOLDERS NEARLY $1 BILLION MEDIPHARM'S BOARD CANNOT BE TRUSTED TO CREATE SHAREHOLDER VALUE OR OVERSEE MANAGEMENT! COMPANY LEADERSHIP LACKS ANY CREDIBLE STRATEGIC PLAN AND HAS MADE NUMEROUS RECKLESS ACQUISITIONS WHILE REWARDING THEMSELVES WITH EXCESSIVE COMPENSATION FOR REPEATED FAILURES APOLLO'S NOMINEES BRING SIGNIFICANT TURNAROUND, M&A, AND OPERATIONAL EXPERIENCE IN CANNABIS AND ADJACENT INDUSTRIES, AND WILL EXECUTE PLAN TO RESTORE VALUE FOR ALL MEDIPHARM SHAREHOLDERS URGES MEDIPHARM SHAREHOLDERS TO VOTE FOR WHOLESALE CHANGE AT ANNUAL MEETING SENDS LETTER TO MEDIPHARM SHAREHOLDERS AND FILES PROXY CIRCULAR TORONTO, ON , MAY 8, 2025 /PRNEWSWIRE/ -- APOLLO TECHNOLOGY CAPITAL CORPORATION ("APOLLO"), WHICH TOGETHER WITH ITS AFFILIATES AND ASSOCIATES COLLECTIVELY IS ONE OF THE LARGEST SHAREHOLDERS OF MEDIPHARM LABS CORP. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MEDIPHARM", "MEDIPHARM LABS", OR THE "COMPANY"), OWNING APPROXIMATELY 3.0% OF THE COMPANY'S COMMON STOCK, TODAY FILED A DISSIDENT INFORMATION PROXY CIRCULAR (THE "CIRCULAR") IN CONNECTION WITH ITS INTENTION TO NOMINATE SIX HIGHLY QUALIFIED DIRECTOR CANDIDATES TO MEDIPHARM'S BOARD OF DIRECTORS (THE "BOARD") AT THE COMPANY'S UPCOMING 2025 ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 10, 2025 (THE "ANNUAL MEETING").

APOLLO TECHNOLOGY CAPITAL CORPORATION TO NOMINATE SIX HIGHLY QUALIFIED DIRECTORS TO MEDIPHARM LABS' BOARD OF DIRECTORS FOLLOWING YEARS OF SHAREHOLDER VALUE DESTRUCTION

PROPOSED BUSINESS COMBINATION TO CREATE A NORTH AMERICAN TECHNOLOGY COMPANY WITH AN AI-DRIVEN FINTECH MARKETPLACE. COMBINED COMPANY TO APPLY FOR LISTING ON NASDAQ AND TSX TORONTO , MARCH 25, 2024 /PRNEWSWIRE/ -- NOBUL AI CORP. ("NOBUL") AND CHECK-CAP LTD.

NOBUL AI CORP AND CHECK-CAP LTD ENTER INTO DEFINITIVE BUSINESS COMBINATION AGREEMENT

TORONTO , DEC. 22, 2023 /PRNEWSWIRE/ - SYMETRYX CORPORATION ("SYMETRYX"), A CANADIAN VENTURE COMPANY, IS PLEASED TO ANNOUNCE THAT THE SHAREHOLDERS OF CHECK-CAP LTD. (NASDAQ: CHEK) VOTED OVERWHELMINGLY TO ELECT ALL THE DIRECTOR NOMINEES PROPOSED BY SYMETRYX AT THE ANNUAL GENERAL MEETING HELD ON DECEMBER 18 TH 2023.

SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD

SYMETRYX RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER SYMETRYX RECOMMENDS VOTING FOR THEIR QUALIFIED INDEPENDENT BOARD NOMINEES TIME IS SHORT - THE VOTE DEADLINE IS 11:59 PM EST THURSDAY DECEMBER 14 TH 2023 - SHAREHOLDERS MAY VOTE OR CHANGE A PREVIOUSLY CAST VOTE UNTIL THAT TIME TORONTO , DEC. 13, 2023 /PRNEWSWIRE/ - FURTHER TO ITS NEWS RELEASE OF NOVEMBER 28, 2023,SYMETRYX CONTINUES TO URGE ITS FELLOW CHECK-CAP LTD. ("CHECK-CAP") (NASDAQ: CHEK) SHAREHOLDERS TO VOTE AGAINST THE KEYSTONE DENTAL AND FOR THE SYMETRYX SLATE OF HIGHLY QUALIFIED AND INDEPENDENT DIRECTOR NOMINEES.

CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL

TORONTO , DEC. 8, 2023 /PRNEWSWIRE/ - FURTHER TO ITS NEWS RELEASE OF NOVEMBER 28, 2023, SYMETRYX CONTINUES TO URGE ITS FELLOW CHECK-CAP LTD. ("CHECK-CAP") (NASDAQ: CHEK) SHAREHOLDERS TO VOTE AGAINST THE KEYSTONE DENTAL AND FOR THE SYMETRYX SLATE OF HIGHLY QUALIFIED AND INDEPENDENT DIRECTOR NOMINEES.

CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

TORONTO , DEC. 5, 2023 /PRNEWSWIRE/ - TODAY, SYMETRYX CORPORATION ("SYMETRYX") ONCE AGAIN ENCOURAGES OUR FELLOW SHAREHOLDERS OF CHECK-CAP LTD. ("CHECK-CAP") (NASDAQ: CHEK) TO REVIEW THE NEWS RELEASE ISSUED BY YOAV KIMCHY, PHD, THE FOUNDER AND FORMER CHIEF TECHNOLOGY OFFICER, AND SHAREHOLDER, OF CHECK-CAP, WHO HAS STATED IN AN OPEN LETTER TO HIS FELLOW SHAREHOLDERS THAT THE VALUE OF THE INTELLECTUAL PROPERTY OF CHECK-CAP WAS, IN ESSENCE, DISREGARDED AND ASSIGNED NO MONETARY VALUE WHEN VALUING THE KEYSTONE DENTAL TRANSACTION.

CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES

RECOMMENDS FELLOW SHAREHOLDERS VOTE AGAINST KEYSTONE TRANSACTION & THE CHECK-CAP BOARD NOMINEES - FURTHER RECOMMENDS A VOTE FOR THE SYMETRYX SLATE OF DIRECTOR CANDIDATES CITES UNREALISTIC AND AGGRESSIVE VALUATION OF KEYSTONE USED TO JUSTIFY THE MERGER AND TROUBLING CASH BURN BY CHECK-CAP BOARD & MANAGEMENT TORONTO , NOV. 28, 2023 /PRNEWSWIRE/ - SYMETRYX, A HOLDER OF 5.6% OF CHECK-CAP LTD. (NASDAQ: CHEK) SHARES, TODAY ISSUED THE FOLLOWING OPEN LETTER TO SHAREHOLDERS.

SYMETRYX TODAY ISSUES OPEN LETTER TO SHAREHOLDERS IN REGARD TO THE UPCOMING ANNUAL GENERAL MEETING

Q3 REVENUE INCREASED 18.9% YEAR-OVER-YEAR TO $16.8M, INCLUDING $11.9M FROM THE U.S. CHECK-CAP SHAREHOLDERS TO VOTE ON PROPOSED BUSINESS COMBINATION AGREEMENT WITH KEYSTONE DENTAL AT ANNUAL GENERAL MEETING ON MONDAY, DECEMBER 18TH, 2023 IRVINE, CALIF., NOV. 28, 2023 (GLOBE NEWSWIRE) -- KEYSTONE DENTAL HOLDINGS (KEYSTONE DENTAL OR THE COMPANY), A PIONEER IN DENTAL IMPLANT TECHNOLOGY, ANNOUNCED TODAY FINANCIAL RESULTS AND PROVIDED A CORPORATE UPDATE FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2023.

Check-Cap Ltd.

CHEK

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Check-Cap Ltd.

CHEK.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

CHEK